“After 20 weeks, what we found for the first time in a randomized controlled trial is that an intensive lifestyle intervention, without drugs, significantly improved cognition and function in many patients who had mild cognitive impairment or early-stage AD.” … […]
This is more nuanced than I wanted to believe at first. Before you scoff, it’s worth a read to understand their criticisms. However, the FDA may still approve the therapy. ~ learn more
It’s a bio-engineered plant that yields purple colored tomatoes with extra anti-oxidants. This newsletter first linked to a write-up about the company in September 2021, so it’s cool to see it start shipping. “Seeds are available at www.norfolkhealthyproduce.com. Packets of 10 high […]
It’s neither a cigarette nor a vape. The FDA authorized the marketing of it with ‘reduced exposure claim’ a couple years ago, but a patent dispute has kept the device out of the US so far. “Japan’s massive reduction in […]
“The company hasn’t yet shown that its drug actually extends lifespan, but the FDA decision signals the agency’s confidence in Loyal’s approach, and the drug will soon be tested in a bigger trial.” ~ learn more
A bit of publicity almost killed this startup, Bobbie, by drawing the attention of regulators to their pilot. This is the story of how they turned the situation around and capitalized on the moment. A couple years since this article […]
From Alex Tabarrok in Marginal Revolution: “The FDA has a long history of antipathy towards personal testing. The FDA has opposed personal pregnancy tests, HIV tests, genetic tests, and COVID tests, as I discussed in my article Testing Freedom. Well, […]
This is mostly about a category of products called relaxers. They are used by women to straighten their hair. The author notes that they seem safe because they’re sold in stores, but they are not regulated by the FDA and […]
Semaglutides came on the scene after last year’s FDA approval. “Until now, doctors didn’t really use medication to treat obesity; the drugs either didn’t work or had too many side effects. … Semaglutide marks the start of a new generation of […]
“Deregulated device types show increases in entry, innovation, as measured by patents and patent quality, and decreases in prices. Safety is either negligibly affected or, in the case of products that come under potential litigation, increased.” | learn more